Merry Christmas!

+
XXX
XXXXX
XXXXXXX
XXXXXXXXX
"BUON ANNO"
"JOYEUX NOEL"
"VESELE VANOCE"
"MELE KALIKIMAKA"
"NODLAG SONA DHUIT"
"BLWYDDYN NEWYDD DDA"
"GOD JUL"
"FELIZ NATAL"
"BOAS FESTAS"
"FELIZ NAVIDAD"
"MERRY CHRISTMAS"
"KALA CHRISTOUGENA"
"VROLIJK KERSTFEEST"
"FROHLICHE WEIHNACHTEN"
"BUON NATALE-GODT NYTAR"
"HUAN YING SHENG TAN CHIEH"
"WESOLYCH SWIAT-SRETAN BOZIC"
"MOADIM LESIMHA-LINKSMU KALEDU"
"HAUSKAA JOULUA-AID SAID MOUBARK"
"'N PRETTIG KERSTMIS"
"ONNZLLISTA UUTTA VUOTTA"
"Z ROZHDESTYOM KHRYSTOVYM"
"NADOLIG LLAWEN-GOTT NYTTSAR"
"FELIC NADAL-GOJAN KRISTNASKON"
"S NOVYM GODOM-FELIZ ANO NUEVO"
"GLEDILEG JOL-NOELINIZ KUTLU OLSUM"
"EEN GELUKKIG NIEUWJAAR-SRETAN BOSIC"
"KRIHSTLINDJA GEZUAR-KALA CHRISTOUGENA"
"SELAMAT HARI NATAL - LAHNINGU NAJU METU"
"SARBATORI FERICITE-BUON ANNO"
"ZORIONEKO GABON-HRISTOS SE RODI"
"BOLDOG KARACSONNY-VESELE VIANOCE "
"MERRY CHRISTMAS - - HAPPY NEW YEAR"
"ROOMSAID JOULU PUHI -KUNG HO SHENG TEN"
"FELICES PASUAS-EIN GLUCKICHES NEWJAHR"
"PRIECIGUS ZIEMAN SVETKUS SARBATORI VESLLE"
"BONNE ANNEBLWYDDYN NEWYDD DDADRFELIZ NATAL"
XXXXX
XXXXX
XXXXX

Germany - The Electronic Health Card

With the introduction of the new card approx. 80 million people with statutory and private health insurance, 21,000 pharmacists, 123,000 registered doctors, 65,000 dentists, 2,200 hospitals as well as the private and statutory health insurance providers will be connected to each other. A project on this scale is unique in Europe and represents an enormous technical and organisational challenge. That is why the Electronic Health Card will not be able to do everything from the outset. It will be gradually expanded with new functions.

The new Electronic Health Card can do much more: whereas the old Health Insurance Card only had a simple memory chip, the new Electronic Health Card contains a microprocessor chip. This chip is programmable and can execute many different tasks.

For example, prescriptions will no longer be issued on paper in future. They will be made available to you in electronic form with the help of the card.

In addition, you can have personal health data saved using the card. For example, this can be basic medical data for emergency care or documentation of medication taken to inform the doctor or pharmacist treating the patient.

Protection of the data is clearly regulated by means of a comprehensive security concept. An encryption process ensures that information saved about you is always protected against unauthorised access. Furthermore, sensitive health data can be accessed only in conjunction with an electronic Health Professional Card. This is a personal card for doctors, dentists, pharmacists and other personnel with authorised access, for example.

The Electronic Health Card is an important step in the modernisation of health systems; it contains many chances and opportunities. This brochure is designed to give a first overview.

Download:

• "The Electronic Health Card" (.pdf, 294 KB, English version)
• "The Electronic Health Card" (.pdf, 350 KB, German version)
• "The Electronic Health Card" (.pdf, 303 KB, French version)

Published by: Federal Ministry of Health, Public Relations Section, 11055 Berlin, Germany

For further information, please visit:

http://www.die-gesundheitskarte.de

Sources

http://www.ehealthnews.eu/content/view/835/62/

http://www.eahp.eu/asp/monitor_news_detail.asp?ID=110&m=11

Hospital Pharmacist Conference 2008

Hospital Pharmacy Conference 2008 "New directions for pharmacy"

Thursday 31 January 2008

Royal Pharmaceutical Society
1 Lambeth High Street
London
SE1 7JN

Contact
Emma Kerby-Evans
+44 (0)20 7572 2414
email: emma.kerby-evans@pharmj.org.uk

Exhibition/sponsorship
Stuart Thomas
+44 (0)20 7572 2224
email: stuart.thomas@rpsgb.org

Source

http://www.pjonline.com/reports/hp/index.html

The European Association of Hospital Pharmacists (EAHP) Guidance for the Handling of Gene Medicines

A new issue of our favorite journal is out there for us all to read. The EJHP European Journal of Hospital Pharmacy - Practice and the EJHP European Journal of Hospital Pharmacy - Science. The section we like more, the country focus, is dedicated to Sweden (Country focus: Hospital Pharmacy in Sweden).

THE HEALTHCARE SYSTEM IN SWEDEN
CLINICAL PHARMACY IN SWEDEN
APODOS: THE SWEDISH MODEL OF MULTI-DOSE
INTERVIEW WITH JOAKIM PETTERSSON, POLITICAL ADVISER AT THE SWEDISH MINISTRY OF HEALTH AND SOCIAL AFFAIRS

We think that the the European Association of Hospital Pharmacists (EAHP) guidance for the handling of gene medicines, is very important and an article published once in a decade. We must translate this guide to all the languages of the European Union!

Congradulations to the authors (Arnold G Vulto, PharmD, PhD; Nicola Stoner, BSc (Hons), MRPharmS, Dip Clin Pharm, PhD; Hana Balásová, PharmD; Ana-Cristina Cercos, PharmD, PhD; Torsten Hoppe-Tichy, PhD; Juan L Vinent Genestar, PharmD; Kirsi Kontra, PharmLic; Per Nydert, MScPharm8; András Vermes, PharmD, PhD; Andrea Wolfsberger, PharmD)

The article is here: http://www.eahp.eu/upload/ejhp/CoverStory29-39.pdf

Google says working to solve health record dilemma

SAN FRANCISCO (Reuters) - Google Inc aims to apply Web search technology to a general set of health information problems and remains committed to the market despite slow initial progress, an executive said on Wednesday.

"We do have a broad interest in this area," Marissa Mayer, Google's vice president of Search Products & User Experience, told Internet industry leaders at the Web 2.0 Summit in San Francisco. "It will start with search."

Mayer said engineers stumbled onto Google's potential role in the field by noticing the number of searches users perform with its Web search services for hard-to-diagnose health problems, often simply by typing symptoms into a Web browser.

"Google is not a doctor, but people come to us with a lot of health information searches," Mayer told the audience of several hundred executives, financiers and writers. "There is a big user information need, which we should ultimately fill."


Source

For more info: REUTERS
Thu Oct 18, 2007 8:48am EDT, By Eric Auchard

Join the energy revolution!

Renewing the UK National Health System

The UK has launched a review of the National Health Service (NHS) to examine the impact of technology and lifestyle choices on the nation's well-being and to make the system more fair, personal and effective.

Launching the review, UK Premier Gordon Brown also announced the creation of a new health innovation fund.

"Our vision...is an NHS that not only provides a personal service that is organised around the needs of the patients but one that is pioneering new cures for the future. Renewing the NHS is my most immediate priority in the job that I hold,'' said UK Prime Minister Gordon Brown as he launched a reportexternal setting out the Government's vision for the country's future health service.

The interim report, NHS next stage review external , published on 4 October 2007, sets out a 10-year vision for the British health service. The report looks at how the NHS can become fairer, more personalised, effective and safe and sets out actions that should be taken to make progress towards that vision. "This interim report is the start of developing this vision for the next ten years," said Lord Darzi, author of the report.

Led by the new health minister, Lord Ara Darzi, the review will examine the impact of technology and lifestyle choices on the nation's well-being, and will look to make the NHS more responsive and better able to serve the needs of the public. The final part of the review setting out how the vision can be delivered will be published in spring 2008.


Source

http://www.euractiv.com/en/health/uk-rethinks-national-health-service/article-167392

The Impact of Technology on Healthcare Delivery

The World of Health IT Conference will take place October 22-25 in the Austria Center, Vienna, Austria.

The electronic version of the World of Health IT Conference, Exhibition & Networking Programme can be viewed online or downloaded here.

The event is designed by and for healthcare professionals involved in the everyday application, management and advancement of healthcare IT across Europe, the Middle East and Africa.

For group registrations please contact:

Tina Luke
Tel: +1.312.915.9516
cluke@himss.org

Jaime Paton
Tel: +1.312.915.9214
jpaton@himss.org

Source

http://www.worldofhealthit.org/

A Design Concept for Diabetes Management Devices

The blogger Amy Tenderich posted her “Open Letter to Steve Jobs” in April, pleading with the Apple CEO to apply some of that company’s design expertise to improving the lives of the 20 million American diabetics who rely on technology to manage their condition every day. Amy’s blog post got a lot of attention, even making its way to TechCrunch.

The company Adaptive path spent time with diabetics, who showed them their routines and talked about how hard it can be to stay motivated to keep them healthy. They shared their experiences with the technology products that they literally depend on for their lives. With their insights, the scientists in Adaptive path were able to came up with dozens and dozens of possible design concepts, sketching out different approaches to achieving those goals. Out of those concepts, a few key elements started to fall into place. They looked at the solutions out on the market and talked to diabetes educators about what works for people and what doesn’t.

They built on those concepts by fleshing out the interaction design of the product, mapping out how the users would monitor their condition and give themselves insulin. At this point, it became clear that a bunch of interface mockups wouldn’t be enough to convey their ideas. That’s when they started producing this video.

The video doesn’t stand alone. They’ve provided all the background on the thinking behind the Charmr concept, including their research findings, as part of their case study. It’s been an exciting project that has pushed them in unexpected ways — in other words, just the kind of project they had hoped for.

High quality video of Charmr (18 MB)

Sources

http://www.adaptivepath.com/blog/2007/08/14/charmr-a-design-concept-for-diabetes-management-devices/
http://www.diabetesmine.com/2007/04/an_open_letter_.html
http://www.youtube.com/watch?v=VQe1tssyGkU
http://www.adaptivepath.com


Thanks to Simon for the links :)

Hospital pharmacy tools

Thomson Healthcare Micromedex provides many products (DrugDex, Martindale, PoisinDex, Drug Reax) and solutions that are being used in many hospital pharmacies all over the world.

Hospital pharmacy workflow tool identifies high-risk patients, manages intervention tasks, and provides reporting on intervention status and outcomes. Provides desktop and mobile access to comprehensive patient and clinical data – including demographics, medications, lab results, as well as relevant Micromedex referential data.

Many Hospital Pharmacies still rely on “paper and eyeballs” to identify and manage high-risk patient populations. The Pharmacy Intervention Solution automates identification and tracking, so pharmacists can spend less time on bookkeeping and more time being clinicians.

For more details: http://www.thomson.com/

Summit on Biotechnology by the European Academy for Hospital Pharmacy (EurAHP)

EurAHP (European Academy for Hospital Pharmacy), that was founded by the EAHP (European Association of Hospital Pharmacists), educates the Hospital Pharmacists in those subjects that are insufficient in the basic programs of study of Pharmacy.

The first program, “Train The Trainers, TTT”, will begin with the Seminar of Biotechnology, in Malta from 3 until 5 October 2007. The training that will be given in participating will be propagated in entire Europe to the Hospital Pharmacists. This educational Seminar of Biotechnology is the first in a line of programmed educational activities in order to face a wide spectrum of subjects in the area of Hospital Pharmacy.

AMGEN (http://www.amgen.com/) is the sponsor of EurAHP at the present moment and other sponsors is expected at an early date.

The EurAHP is managed by a Steering Committee (SC)
The Steering Committee is responsible for adequate execution and performance of the project, for the nomination of EurAHP Faculty members and the evaluation of the outcome.

The EurAHP Governance Board (GB)
The EurAHP Governance Board ensures that the Steering Committee’s decisions are taken in full independence.

The EurAHP Advisory Board (AB)
The role of the EurAHP Advisory Board is to propose educational topics, potential faculty and all other organisational aspects (such as ways to execute the teaching programmes on a national / local level) to the EurAHP Steering Committee.

Participants of the TTT (“Train the Trainer”) programme have been nominated by their national associations and are willing and able to disseminate the knowledge at a national level with the support of their national association. Participants will be trained as teachers and are expected to hold 1 to 5 seminars at national level depending on the size and needs of their own country.

The first program, Train the Trainer Workshops, will start with the Summit on Biotechnology, a "train the trainer" session, Malta on 3 to 5 October 2007.

Source
http://www.eahponline.com/upload/ejhp/EAHPNews(12).pdf

Pharmacy respect

Source

http://www.youtube.com/watch?v=sGip7x-sIuo

Results of the EAHP, European Association of Hospital Pharmacists, Survey 2005

In the year 2005, EAHP (European Association of Hospital Pharmacists) organized a pan-European survey concerning the status of hospital pharmacy.

The survey was carried out by 22 out of 26 EAHP country members and provided data from 825 hospitals. The analysis of the results is presented as a comparison between the countries and, where possible also the comparison between the results of previous surveys that took place in the year of 1995 and 2000.

You can download the .pdf file from the address: http://www.eahp.eu/download/EAHP%202005%20Survey.pdf

Source

http://www.eahp.eu/asp/survey.asp?m=7

A health economics survey of European Hospital Pharmacists

A very important scientific paper has been published in the EJHP Science (European Journal oh Hospital Pharmacy Science).

A qualitative survey, which was designed based on an earlier questionnaire developed and validated in the UK, was administered to all consenting hospital pharmacists attending the 9th Congress of the European Association of Hospital Pharmacists (EAHP) held in Seville, Spain, 17-19 March 2004.

A total of 108 pharmacists attending the congress, from 14 different countries, participated in the survey. Pharmacists from the UK (n=33), France (n=16), Spain and Belgium (n=13 each), and Portugal (n=11) represented approximately 31%, 15%, 12%, and 10% of the survey population respectively. Other participants represented the Netherlands (6), Switzerland (4), Greece (3), Sweden (2), Germany (1), Denmark (1), Norway (1), Israel (1) and Malaysia (1). Two participants did not list their country of origin.

ABSTRACT

Study objectives: To explore the health economics knowledge base of hospital pharmacists and the level of importance they attribute to different sources of health economic evidence and types of analyses in relation to hospital formulary drug selection processes.

Methods: A brief health economics survey was conducted using an English-language paper questionnaire administered to 108 consenting hospital pharmacists attending a European congress in March 2004.

Results: Although more than 80% (n=88) of participants reported participating in drug selection processes, 43% (n=47) rated themselves in relation to health economics as not very knowledgeable, and 44% (n=47) reported having no formal training in this area at all. Clinical opinion and published reviews were preferred to published economic evaluations and economist opinion as sources of economic evidence. Cost-effectiveness and budget impact analyses were identified as either essential or very important by 88% (n=45) and 74% (n=38) of participants, respectively, who reported using the results of economic analyses in drug selection decisions (n=51). Barriers to the use of economic evaluations were lack of time to evaluate results, lack of availability, difficulty analysing results and poor transparency, in this order.

Conclusion: Hospital pharmacists are central to the hospital formulary drug selection process. Health economists should be more proactive in their support of this group of professionals, either through initiatives aimed to help expand their health economics knowledge base, or by making a more concerted effort to collaborate with clinical experts in the dissemination of economic data
in timely and transparent drug reviews.

Krista Payne, MEd, Irina Proskorovsky, BSc
Caro Research Institute

Source

You can find the whole paper and full contact details for the authors in the following address (it's the homepage of EAHP European Association of Hospital Pharmacists, subpage of the Journal): http://www.eahp.eu/upload/ejhp/Payne.pdf

EAHP -European Association of Hospital Pharmacists - has two new members, Serbia and Turkey

EAHP -European Association of Hospital Pharmacists- is a community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Croatia, Norway, Serbia, Switzerland and Turkey (I mention the countries in the alphabetical order :)).

Membership is increasing each year and, at present, EAHP represents the interest of over 21,000 hospital pharmacists all over Europe. Any Association of Hospital Pharmacists from any country who is a member in the Council of Europe can join the EAHP.

The new members are the Hospital Associations from


Serbia






and Turkey.






Welcome dear colleagues from Serbia and Turkey.

PharmaCon2007 Conference, Dubrovnik, Croatia

Pharmacon is an event that once a year gathers all pharmacy stakeholders, best thinkers and movers, ranging from students and practitioners to industrial and institutional representatives, in order to share possessions of incalculable value, their ideas...

The recent Pharmacon2007 took place in Dubrovnik, Croatia, May 22 to 27, 2007. The theme was "European Congress on Future of Pharmacy, New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education".

The very important presentations are ready to be presented in the address:

http://www.slideshare.net/tag/pharmacon2007/

Thank you Simon for the link ;)

7th Spring Conference on Clinical Pharmacy - ESCP

Clinical and Hospital Pharmacists from all over Europe, United States and Asia attended the 7th Spring Conference on Clinical Pharmacy - ESCP (Eropean Society of CLinical Pharmacy) in Edimburgh, Scotland.

The main theme of the Congress was "Tackling Inequalities in the Delivery of Pharmaceutical Care".

The next congress of ESCP will take place in Turkey, from 25 to 27 October 2007. For more details please visit the address: http://www.escpweb.org/istanbul/

Here are some photos from the congress in Edimburgh:

High-Performance Pharmacy

There is a new website named "the High Performance PharmacySM Web Site", based on a landmark study by The Health Systems Pharmacy Executive Alliance. The study identifies proven best practices for achieving high performance across 8 dimensions of hospital pharmacy practice.

The High Performance Pharmacy^SM project, an ongoing initiative of the Health Systems Pharmacy Executive Alliance, seeks to identify how hospital pharmacies can enhance their performance—and prominence—within the health systems they serve. The High Performance Pharmacy study, the latest product of the Executive Alliance's research, identifies the 8 areas, or "dimensions," in which hospital pharmacies should strive to achieve high performance.

The 8 dimensions are:

1. Leadership
2. Medication preparation and delivery
3. Patient care services
4. Medication safety
5. Medication use policy
6. Financial performance
7. Human Resources management
8. Education

Building on the 8 dimensions, the High Performance Pharmacy study identifies over 70 performance elements—structures, policies, procedures, activities, and practices—that serve as indicators of high performance and result in a financial or clinical return on investment of resources.

Follow the links to learn more about each dimension, its elements, and the solutions available to help you become a High Performance Pharmacy.

Sources

http://www.medscape.com/viewarticle/555043?src=mp

http://www.highperformancepharmacy.com/index.php

1 Comments:

BelArt said...

Yes, this site is very useful for people who afraid sometimes buy pharmacies by the reason of not knowing their usage. Everything is explain on this site.

Sunday, May 27, 2007 5:16:00 PM

1st International Conference on "Natural Health and Nutrition. A Scientific Approach"

According to Hippocrates "a therapy's highest aspiration is the immediate, gentle and permanent restoration to good health as well as the disappearance of an illness in its entirety in the fastest, most correct and most harmless way". A similar approach is being adopted by an increasing number of people from all over the world who are searching for alternative practices in health and nutrition in their efforts to find remedies for both old and new physical and psychological health problems.

According to many modern alternative therapy practitioners, physical symptoms that are caused by an illness or a disorder must be considered in relation to the emotional, intellectual and spiritual well-being of a person. This relationship helps the therapist to go deeper into the patient's health problem and then to apply the necessary holistic therapies and dietary methods. If these practices are applied in combination with traditional medicine they will make up an integrated approach to patients, restoring them fully by healing not only the symptoms but also their causes.

The aim of the 1st International Conference on "Natural Health and Nutrition. A Scientific Approach", which will take place for the first time in Athens in October 2007, is to deal with this subject within the framework of scientific research and knowledge and at the same time to make known the extremely valuable contribution made by the alternative methods and the dietary therapies in maintaining good health whilst showing respect to people and to Mother Earth precious goods.

Scientists and researchers from all over the world will take part as speakers at the conference and will give answers to hot questions that concern many people whilst presenting new scientific facts that will immediately be applied in practice and will contribute to the achievement of the conference's goals.

Moreover, the general public today expects health professionals to keep them informed about natural therapies and to apply suitable dietary therapies. We therefore invite all those who are directly or indirectly involved in this sensitive and essential area to be present and contribute to the success of this conference.

Attendants

	Pharmacists
	Medical doctors
	Dieticians
	Psychologists
	Physiotherapists
	Homeopath doctors
	Naturopaths
	Herbalists
	Acupuncturists
	Osteopathics
	Chiropractors
	Researchers and writers on health and nutrition
	Cosmeticians
	Wellness coaches
	Nurses
	Undergraduate and postgraduate students on the field of health and nutrition.

and all people concerning about their health and nutritional intake.

Oral or poster presentations are welcome on the topics mentioned on the Topics web page.

Interested contributors are kindly asked to submit their abstracts (english or greek) electronically

by 17 May 2007.

An abstract of up to 300 words should be submitted, stating clearly the scope of the paper to be presented, the scientific methodology applied and the results obtained.

All abstracts will be reviewed by the Program Committee, and the authors will be notified about acceptance of their paper by 15 June 2007.

Full papers should be submitted by 10 August 2007.

ORGANIZERS

Heliotopos Conferences

Address: 28, Ypsilantou str.,
GR-17236, Dafni-Athens, Greece
Phone: +30 210 9730697
Fax: +30 210 9767208
E-mail: conf@heliotopos.net

NatHeal2007
Conference Secretariat E-mail: NatHeal2007@heliotopos.net

Source

http://natheal2007.conferences.gr/index.php?id=3891

12th Congress of the EAHP, 21 – 23 March 2007, Bordeaux, France

Hospital Pharmacists and other scientists from the health care sector were attended the 12th Congress of the EAHP from 21 – 23 March 2007 in Bordeaux, France.

The main theme of the congress was “New therapies in the 21st century: Challenges for hospital pharmacy”.

Among the seminars and presentations were the following topics:

How is genome technology affecting therapy in hospital pharmacy practice?
Speaker: William E Evans, PharmD, St Jude Children's Research Hospital, Memphis, TN, USA

How are new pharmaceuticals tested in humans after the March 2006 tragic outcome in London?
Speaker: Dr Nirmala Bhogal, FRAME, Nottingham, UK

Future for the free research and drug development
Speaker: Merrill Goozner, Center for Science in the Public Interest, Washington DC, USA


Seminars

Seminar1: Drugs of the 21st century: biopharmaceuticals and biosimilars
Speaker A: Professor Roger L Tredree, St George’s Hospital, London, UK
Speaker B: Professor Huub Schellekens, Institute of Innovative Studies, University of Utrecht, Utrecht, The Netherlands

Seminar2: Effect of genetic information on hospital pharmacy practice
Speaker A: Dr Philippa Brice, UK
Speaker B: V'Iain Fenton-May, University of Wales, College of Medicine, Wales, UK

Seminar3: Haemato-oncology: cutting edge diagnosis translated in tailor-made therapy
Speaker A: Dr Maria Guadalupe Salta, Instituto Português de Oncologia de Francisco Gentil, Lisbon, Portugal
Speaker B: Professor John Goldman, Imperial College, London, UK

Seminar4: The EAHP 2005 Survey: trends of European hospital pharmacy in the new century
Speaker A: Dr Tajda Miharija-Gala, University Medical Centre Ljubljana, Ljubljana, Slovenia and Director of Professional and Practice Aspects, EAHP

Seminar5: Incompatibility reactions in drug therapy – preventable medication errors
Speaker A: Dr Karin Nemec, Donauspital, Vienna, Austria
Speaker B: Professor Stefan Mühlebach, Swissmedic, Bern, Switzerland

Seminar6: The GMP challenge: Future for production and reconstitution in Hospital Pharmacy
Speaker A: Professor Vagn Handlos, H:S Pharmacy, Copenhagen, Denmark
Speaker B: Kristina Thomsen, Roskilde Hospital, Denmark

Seminar7: National presidents’ seminar: patient safety in the daily life of European hospitals
Speaker A: Dr Jochen Schnurrer, Klinikum Region Hannover, Laatzen, Germany
Speaker B: Veronica Treacy, St James Hospital, Dublin, Ireland
Speaker C: Dr María José Tamés, Instituto Oncológico, San Sebastian, Spain

Seminar8: How does hospital accreditation affect the hospital pharmacies in Europe?
Speaker A: Dr Helle Mc Nulty, H:S Pharmacy, Copenhagen, Denmark
Speaker B: Dr David Marx, Charles University, Prague, Czech Republic

Seminar9: Drugs available in the EU – future shortage?
Speaker A: Dr Walter Deutschmann, Klinikum Bremen Mitte, Bremen, Germany
Speaker B: Rui Dos Santos Ivo, European Commission, Brussels, Belgium

Seminar10: Reengineering hospital pharmacy in Europe: changing from cost to care centres
Speaker A: Dr Jorgen Garnak, IMS Health, London, UK
Speaker B: Dr Maria Antònia Mangues, Hospital de la Sta Creu I St Pau, Barcelona, Spain

Seminar11: How to organize a clinical trial unit?
Speaker A: Dr John Jolley, London, UK
Speaker B: Dr Monika Seibert-Grafe, Mainz, Germany

Seminar12: Is purchasing drugs a role for the hospital pharmacy in the future?
Speaker A: Flemming Sonne, Amgros I/S, Copenhagen, Denmark
Speaker B: Dr Michael Baehr, University Medical Center Hamburg-Eppendorf, Hamburg, Germany


Satellite Symposium

Biocompatibles: Drug Eluting Beads, A novel Drug Delivery Embolisation System in Oncology

BioGeneric drugs: the next breakthrough

Planning for patient safety

The rational use of biologic therapy in inflammatory diseases


The next 13th Annual Congress of the European Association of Hospital Pharmacists will take place in Maastricht, The Netherlands, from 27 to 29 February 2008.

Here are some photos from the 12th congress.